Skip to content
Cost Savings

GoodRx Employer Direct: Employers Can Now Offer Wegovy, Zepbound KwikPen and Foundayo Outside the Health Plan

5 min readBy Jeremy H., GLP-1 Nutrition Researcher
GoodRx Employer Direct: Employers Can Now Offer Wegovy, Zepbound KwikPen and Foundayo Outside the Health Plan

On October 29, 2026, GoodRx announced the market-wide launch of Employer Direct, a weight loss offering that lets employers help employees access FDA-approved GLP-1 medications for weight management outside the traditional pharmacy benefit. The announcement came one day after WTW reported that employer GLP-1 coverage for weight loss fell to 53%, down from 57%.

Employer Direct is built for the gap that survey describes: employers that want to support GLP-1 access but do not cover these drugs under their health plan, or want a more predictable way to pay for them.

The five medications

Employer Direct provides access to employer pricing made available by the manufacturers for five medications:

  • Wegovy (semaglutide) — the weekly injection pen.
  • Wegovy HD (semaglutide) — Novo Nordisk's higher-dose weekly pen, 7.2 mg.
  • Wegovy pill (oral semaglutide) — the once-daily tablet form of semaglutide.
  • Foundayo (orforglipron) — Eli Lilly's once-daily oral GLP-1.
  • Zepbound KwikPen (tirzepatide) — Eli Lilly's tirzepatide in the KwikPen device.

GoodRx collaborates with Novo Nordisk on employer pricing, and serves as an approved independent program administrator for Lilly Employer Connect, Eli Lilly's employer platform. The announcement does not break down which manufacturer channel covers each of the five medications. Wegovy employer pricing is available at retail pharmacies nationwide, according to Novo Nordisk.

How employers choose medications and contributions

Employer Direct puts three decisions in the employer's hands:

Choose the medications. Employers determine which of the five eligible FDA-approved GLP-1 medications for weight management to include. An employer can offer all five or a subset, based on workforce needs and benefits strategy.

Set the contribution. Employers choose how much to contribute toward the manufacturer pricing, as a fixed amount, a percentage, or full coverage. Contributions are applied automatically when prescriptions are filled, with no reimbursement step for the employee.

Add clinical care. Employers can integrate GoodRx for Weight Loss into the offering, connecting clinical care, transparent pricing, and pharmacy fulfillment. Employees can also participate with a valid prescription from their own healthcare provider.

The offering is designed to complement an employer's existing health plan, not replace it. It provides targeted support for medications that may not otherwise be covered within the traditional benefit.

Implementation in as little as 30 days

GoodRx says employers can configure the offering based on their workforce and benefits strategy, with implementation as quick as 30 days. The offering is available to employers, plan sponsors, consultants, and third-party administrators. Employers interested in the program can learn more at goodrx.com/employerdirect.

Employer Direct builds on GoodRx's existing manufacturer relationships through its Pharma Direct business.

Get GLP-1 price and coverage changes by email

Self-pay prices, savings cards and insurer coverage changes, checked and explained. One free email a week.

GoodRx Companion coming January 2027

Beginning January 2027, employers will also be able to offer GoodRx Companion through Employer Direct. Companion is a fixed monthly subscription that provides free and low-cost generic medications and savings on common healthcare services, including dental, vision, labs, and imaging. Employers can offer Companion on its own or alongside the weight loss offering.

What this means if you are an employee

If your employer does not cover GLP-1s under its health plan, ask your HR or benefits team whether the company offers GoodRx Employer Direct or plans to. Three questions to ask:

  • Which of the five medications are included?
  • How much does the employer contribute — a fixed amount, a percentage, or full coverage?
  • Do you use GoodRx for Weight Loss for clinical care, or do you bring a prescription from your own provider?

Your out-of-pocket cost depends on the answers. GoodRx did not publish per-drug employer prices in the announcement, so the amount you pay is set by your employer's contribution choice, not by a public price list.

If your employer does not offer Employer Direct, manufacturer self-pay programs are the other route to the same brand-name drugs. Our GLP-1 insurance coverage guide covers prior authorization, appeals, and savings programs.

What we could not confirm

  • Exact employee prices. The announcement does not publish dollar prices for the Novo employer pricing or a per-drug employee cost. Pharmaceutical Commerce reported that Lilly Employer Connect makes Zepbound KwikPen available at $449 across all doses, but that figure comes from trade coverage, not from the GoodRx announcement, and we could not confirm it against a primary source.
  • Eligibility rules. The announcement does not state which employees qualify (for example, BMI thresholds or prior authorization rules). Those terms are set by the employer and the plan, so check with your benefits team.

This article is educational information, not medical advice. Talk to your prescriber before starting, changing, or stopping any medication. Pricing and program details were checked in November 2026 and can change.

Sources

  • GoodRx, "GoodRx Launches Employer Direct Weight Loss Offering" (press release, October 29, 2026). Business Wire
  • Pharmaceutical Commerce, "Pharma Pulse: GoodRx Opens Employer GLP-1 Channel, Lilly Fends Off Novo Ad Challenge, PCMA Takes Aim at Wholesalers" (October 2026). Pharmaceutical Commerce
  • WTW, "WTW 2026 Best Practices in Healthcare Survey" (press release, October 28, 2026). GlobeNewswire

Get GLP-1 price and coverage changes by email

Self-pay prices, savings cards and insurer coverage changes, checked and explained. One free email a week.

We respect your privacy. Unsubscribe anytime.

Next up

A few related reads to keep your momentum.

GLP-1 Insurance Coverage: How to Get Approved and Appeal Denials
Cost Savings
Apr 2, 2026
GLP-1 Insurance Coverage: How to Get Approved and Appeal Denials
GLP-1 coverage varies by plan. Here's how to check yours, navigate prior authorization, appeal denials, and find savings programs that work. Updated: CVS Caremark Zepbound reversal, Foundayo formulary addition, Medicare bridge copay correction ($50/mo effective July 1).
GLP-1 Cost Comparison 2026: What You'll Actually Pay
Cost
Apr 3, 2026
GLP-1 Cost Comparison 2026: What You'll Actually Pay
Compare real GLP-1 costs in 2026, with or without insurance — list prices, copays, savings cards, LillyDirect self-pay, generics, Medicare Bridge, Foundayo pricing, and a budgeting framework so you know your true monthly spend.
Wegovy Pill Cost in 2026: Price by Dose
Cost Savings
Oct 4, 2026
Wegovy Pill Cost in 2026: Price by Dose
Current self-pay prices for Wegovy tablets by dose, plus GoodRx Care Direct's separate monthly care-plan fee and the limits to keep in mind.
Zepbound Cost Guide 2026: What You Need to Know Before You Pay
Guides
Apr 17, 2026
Zepbound Cost Guide 2026: What You Need to Know Before You Pay
Zepbound costs over $1,000 per month at list price. Learn how insurance, savings cards, and patient assistance can dramatically reduce your cost.
Orforglipron (Foundayo): Side Effects, Price, and Doses
Medications
Apr 23, 2026
Orforglipron (Foundayo): Side Effects, Price, and Doses
Foundayo (orforglipron) is an FDA-approved daily pill for chronic weight management in eligible adults. Review its indication, FDA-label dose schedule, clinical-trial results, safety information, and current access details.
TrumpRx and GLP-1 Prices: Does It Lower Wegovy or Zepbound Costs in 2026?
Cost Savings
Apr 3, 2026
TrumpRx and GLP-1 Prices: Does It Lower Wegovy or Zepbound Costs in 2026?
TrumpRx does not currently lower GLP-1 drug prices. Wegovy and Zepbound still cost $1,000–$1,400/month at list price. Here is what TrumpRx actually does, what is still uncertain, and what to check before paying.

Related articles

Written by
J
Jeremy H.
GLP-1 Nutrition Researcher

Nutrition researcher and founder of The GLPSpot. Jeremy built this site after watching friends and family struggle with the nutritional challenges of reduced appetite on GLP-1 medications — loss of muscle mass, dehydration, and nutrient deficiencies.

Published:
Medical Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment.